Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Particle3D is a Danish medtech company developing patient-specific, resorbable 3D-printed bone implants for reconstruction of human bone defects. The company was founded as a spin-out from the University of Southern Denmark and built its platform around a proprietary bio-ink and additive manufacturing process for bone-like implants. Particle3D later rebranded to Ossiform, which now markets research-use P3D Scaffolds and is advancing Ossiform Bone implants for orthopedic and craniofacial applications. Its products are designed to support bone ingrowth, vascularization, osseointegration, and gradual resorption, with the long-term goal of replacing conventional foreign-body implants and variable allografts. As of 2026, the company appears to remain preclinical, with ISO 13485 certification and commercialization efforts focused on research products and future implant approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Particle3D.